Machine learning is helping neuroscientists organize vast quantities of cells’ genetic data in the latest neurobiological cartography effort.
News-Medical.Net on MSN
New guidance for the diagnosis and management of inherited hyperbilirubinemia
Inherited hyperbilirubinemia, encompassing Gilbert syndrome, Crigler-Najjar syndrome, Dubin-Johnson syndrome, and Rotor ...
To support clinicians in making informed decisions regarding the diagnosis and management of inherited hyperbilirubinemia, including Gilbert syndrome, Crigler-Najjar syndrome, Dubin-Johnson syndrome, ...
Inherited hyperbilirubinemia, encompassing Gilbert syndrome, Crigler-Najjar syndrome, Dubin-Johnson syndrome, and Rotor syndrome, represents a ...
Indian Defence Review on MSN
The Thin Surface That’s Breaking Light’s Biggest Rule
A new, ultra-thin metasurface is making waves in the world of optics by defying the traditional behavior of light. By ...
Most polymers don’t mix—and that’s the point. Polymer alloys succeed by engineering the interface: use thermodynamics to predict separation, processing to sculpt morphology, and compatibilizers to ...
News-Medical.Net on MSN
Obesity drives shared genetic risk behind many chronic disease combinations
By Dr. Priyom Bose, Ph.D. A sweeping genetic analysis reveals when obesity is the common thread linking chronic diseases, and when other biology is to blame. Study: Genetics identifies obesity as a ...
Study links lifelong lead exposure to 18% of US dementia cases, showing bone lead—not blood levels—may predict Alzheimer’s risk decades later.
MedPage Today on MSN
Safety of Crohn's Disease Meds; Boosting CRC Screening; BMI and Liver Risks
News and commentary from the world of gastroenterology and hepatology ...
BEIJING -- Chinese scientists have launched an ambitious international megascience project to decode the genetic blueprint of ...
For patients taking medications that don't work as expected or pharmaceutical companies struggling with clinical trial failures, MetaOmics-10T represents a new starting point.
Market valued at $1.68B in 2024, projected to reach $4.58B by 2033 at 13.4% CAGR, driven by chronic wound prevalence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results